Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark one) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _________ to _________ Commission File Number: 001-41063 JOURNEY MEDICAL CORPORATION (Exact name of registrant as specified in its charter) D ...

Journey Medical Corporation (NASDAQ:DERM) Q1 2022 Earnings Conference Call May 10, 2022 4:30 PM ET Company Participants Jose Ibrahim - IR Claude Maraoui - Co-Founder, President and Chief Executive Officer Ernie De Paolantonio - Chief Financial Officer Ramsey Alloush - General Counsel Conference Call Participants Kalpit Patel - B. Riley Brandon Folkes - Cantor Fitzgerald Scott Henry - ROTH Capital Operator Ladies and gentlemen, thank you for standing by. Good afternoon and welcome to the Journey Medical Firs ...

Table of Contents Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, par value $0.0001 per share DERM NASDAQ Capital Market UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark one) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition per ...

Table of Contents | --- | --- | --- | |-------------------------------------------|--------------------------------------------------------------------|-------------------------------------------------------------------------| | Securities \nTitle of each class | registered pursuant to Section 12(b) \nTrading Symbol(s) | of the Act: \nName of each exchange on which registered | | Common Stock, par value $0.0001 per share | DERM | NASDAQ Capital Market | UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washi ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark one) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _________ to _________ Commission File Number: 001-41063 JOURNEY MEDICAL CORPORATION (Exact name of registrant as specified in its chart ...